Heritage Investors Management Corp acquired a new position in shares of CVS Health Corp (NYSE:CVS) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 5,465 shares of the pharmacy operator’s stock, valued at approximately $406,000.
Several other institutional investors have also recently added to or reduced their stakes in CVS. RMB Capital Management LLC lifted its position in shares of CVS Health by 2.5% during the 2nd quarter. RMB Capital Management LLC now owns 13,179 shares of the pharmacy operator’s stock worth $718,000 after purchasing an additional 327 shares during the last quarter. National Pension Service lifted its position in shares of CVS Health by 4.5% during the 2nd quarter. National Pension Service now owns 1,367,980 shares of the pharmacy operator’s stock worth $74,541,000 after purchasing an additional 58,477 shares during the last quarter. Private Advisor Group LLC lifted its position in shares of CVS Health by 74.3% during the 2nd quarter. Private Advisor Group LLC now owns 107,624 shares of the pharmacy operator’s stock worth $5,861,000 after purchasing an additional 45,886 shares during the last quarter. Ellington Management Group LLC purchased a new stake in shares of CVS Health during the 2nd quarter worth $779,000. Finally, VisionPoint Advisory Group LLC purchased a new stake in shares of CVS Health during the 2nd quarter worth $219,000. 76.64% of the stock is owned by institutional investors and hedge funds.
CVS has been the subject of several recent analyst reports. Raymond James reaffirmed a “strong-buy” rating and set a $90.00 price objective (up from $80.00) on shares of CVS Health in a research report on Wednesday, December 4th. UBS Group reaffirmed a “buy” rating and set a $78.00 price objective on shares of CVS Health in a research report on Thursday, November 7th. JPMorgan Chase & Co. lifted their price objective on shares of CVS Health from $88.00 to $97.00 and gave the stock an “overweight” rating in a research report on Thursday, December 19th. Mizuho lifted their price objective on shares of CVS Health from $71.00 to $82.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Finally, Cowen set a $76.00 price target on shares of CVS Health and gave the stock a “buy” rating in a research note on Monday, October 21st. One research analyst has rated the stock with a sell rating, six have given a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $77.43.
In related news, EVP Karen S. Lynch sold 80,143 shares of the business’s stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $6,010,725.00. Following the sale, the executive vice president now owns 41,831 shares of the company’s stock, valued at $3,137,325. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Troyen A. Brennan sold 23,604 shares of the business’s stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $68.00, for a total transaction of $1,605,072.00. Following the sale, the executive vice president now directly owns 107,921 shares in the company, valued at approximately $7,338,628. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 161,310 shares of company stock worth $11,796,598. Company insiders own 0.53% of the company’s stock.
Shares of CVS Health stock opened at $73.83 on Wednesday. CVS Health Corp has a 52-week low of $51.72 and a 52-week high of $77.03. The company has a quick ratio of 0.61, a current ratio of 0.92 and a debt-to-equity ratio of 1.32. The company’s 50-day simple moving average is $74.13 and its 200-day simple moving average is $65.22. The firm has a market cap of $93.81 billion, a price-to-earnings ratio of 10.43, a price-to-earnings-growth ratio of 1.54 and a beta of 0.89.
CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.77 by $0.07. CVS Health had a net margin of 1.83% and a return on equity of 15.45%. The business had revenue of $64.81 billion for the quarter, compared to analyst estimates of $62.99 billion. During the same period in the previous year, the business posted $1.73 earnings per share. The business’s revenue was up 36.5% compared to the same quarter last year. Equities research analysts anticipate that CVS Health Corp will post 7.03 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Wednesday, January 22nd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.71%. CVS Health’s dividend payout ratio (DPR) is 28.25%.
CVS Health Profile
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.
See Also: How is diluted EPS different from basic EPS?
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.